Neuronetics (STIM) Competitors $1.15 +0.04 (+3.60%) (As of 12:09 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends STIM vs. TELA, FONR, EDAP, LNSR, VANI, NSPR, ECOR, MLSS, HYPR, and APYXShould you be buying Neuronetics stock or one of its competitors? The main competitors of Neuronetics include TELA Bio (TELA), FONAR (FONR), Edap Tms (EDAP), LENSAR (LNSR), Vivani Medical (VANI), InspireMD (NSPR), electroCore (ECOR), Milestone Scientific (MLSS), Hyperfine (HYPR), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. Neuronetics vs. TELA Bio FONAR Edap Tms LENSAR Vivani Medical InspireMD electroCore Milestone Scientific Hyperfine Apyx Medical Neuronetics (NASDAQ:STIM) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Do insiders & institutionals believe in STIM or TELA? 53.6% of Neuronetics shares are held by institutional investors. Comparatively, 94.4% of TELA Bio shares are held by institutional investors. 9.8% of Neuronetics shares are held by insiders. Comparatively, 6.0% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is STIM or TELA more profitable? Neuronetics has a net margin of -50.09% compared to TELA Bio's net margin of -60.49%. Neuronetics' return on equity of -141.24% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Neuronetics-50.09% -141.24% -32.77% TELA Bio -60.49%-556.18%-63.13% Do analysts recommend STIM or TELA? Neuronetics presently has a consensus price target of $4.67, suggesting a potential upside of 320.42%. TELA Bio has a consensus price target of $9.25, suggesting a potential upside of 209.36%. Given Neuronetics' higher probable upside, equities analysts clearly believe Neuronetics is more favorable than TELA Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neuronetics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer STIM or TELA? In the previous week, TELA Bio had 2 more articles in the media than Neuronetics. MarketBeat recorded 4 mentions for TELA Bio and 2 mentions for Neuronetics. TELA Bio's average media sentiment score of 1.19 beat Neuronetics' score of 0.43 indicating that TELA Bio is being referred to more favorably in the news media. Company Overall Sentiment Neuronetics Neutral TELA Bio Positive Which has more risk and volatility, STIM or TELA? Neuronetics has a beta of 2.26, suggesting that its stock price is 126% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Does the MarketBeat Community favor STIM or TELA? Neuronetics received 69 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.68% of users gave TELA Bio an outperform vote while only 68.45% of users gave Neuronetics an outperform vote. CompanyUnderperformOutperformNeuroneticsOutperform Votes12868.45% Underperform Votes5931.55% TELA BioOutperform Votes5974.68% Underperform Votes2025.32% Which has better earnings & valuation, STIM or TELA? Neuronetics has higher revenue and earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuronetics$71.35M0.47-$30.19M-$1.23-0.90TELA Bio$58.45M2.01-$46.66M-$1.69-1.77 SummaryNeuronetics beats TELA Bio on 11 of the 18 factors compared between the two stocks. Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STIM vs. The Competition Export to ExcelMetricNeuroneticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.35M$4.54B$5.21B$8.91BDividend YieldN/A42.91%5.23%4.05%P/E Ratio-0.9012.6386.2513.46Price / Sales0.4750.501,470.3386.69Price / CashN/A55.4235.2835.09Price / Book0.945.394.935.04Net Income-$30.19M$13.65M$117.66M$224.28M7 Day Performance16.35%2.64%2.86%1.98%1 Month Performance7.77%7.38%1.79%9.78%1 Year Performance-45.32%46.32%35.89%29.97% Neuronetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STIMNeuronetics3.0013 of 5 stars$1.15+3.6%$4.67+305.8%-45.3%$34.90M$71.35M-0.93180TELATELA Bio4.0372 of 5 stars$3.07-2.2%$9.25+201.3%-47.0%$120.92M$68.65M-1.86120Positive NewsFONRFONAR2.553 of 5 stars$16.17-1.8%N/A-16.2%$102.36M$102.88M11.76480Short Interest ↓Positive NewsEDAPEdap Tms3.6127 of 5 stars$2.38-2.5%$19.00+698.3%-51.6%$88.30M$65.42M-3.75307Positive NewsLNSRLENSAR2.2957 of 5 stars$7.48-0.7%$8.00+7.0%+194.9%$86.88M$48.87M-5.16110Positive NewsVANIVivani Medical3.6486 of 5 stars$1.44flat$3.00+108.3%+51.6%$85.30MN/A-3.2020Positive NewsNSPRInspireMD2.3693 of 5 stars$2.84-3.4%$4.50+58.5%+26.6%$74.07M$6.20M-3.7650ECORelectroCore0.7266 of 5 stars$11.24-7.9%N/A+93.0%$73.62M$16.03M-6.3650High Trading VolumeMLSSMilestone Scientific2.2861 of 5 stars$0.93-6.4%$1.25+34.8%+13.9%$72.20M$9.83M-14.1430HYPRHyperfine3.1736 of 5 stars$0.97-3.7%$1.60+64.4%-24.8%$70.98M$13.26M-1.77190Positive NewsAPYXApyx Medical2.7963 of 5 stars$1.87+16.1%N/A-18.5%$70.39M$48.54M-2.25270Positive News Related Companies and Tools Related Companies TELA Competitors FONR Competitors EDAP Competitors LNSR Competitors VANI Competitors NSPR Competitors ECOR Competitors MLSS Competitors HYPR Competitors APYX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:STIM) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuronetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
